NCT01890057View on ClinicalTrials.gov

The Dose of Sugammadex for Rapid Reversal of Profound Neuromuscular Block in Young and Elderly Patients

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Anesthesia Recovery Period, Neuromuscular Blockade
Interventions
DRUG

Sugammadex

The dose of sugammadex

Trial Locations (1)

Unknown

Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Severance Hospital

OTHER

NCT01890057 - The Dose of Sugammadex for Rapid Reversal of Profound Neuromuscular Block in Young and Elderly Patients | Biotech Hunter | Biotech Hunter